Among them, deletions in 4q (FAT1 and FBXW7) and 2q (TRIP12) affect genes that are frequently mutated in some cancer types, suggesting a tumour suppressor role of these ones (Table 2 and Supplementary Table 2). The gene discussed is FAT1; the disease is cancer.